| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.004 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.008 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |